Causal therapy of COVID-19: critical review and prospects
N Beloborodova, E Zuev, M Zamyatin, V Gusarov - 2021 - covid19.neicon.ru
The COVID-19 outbreak started in December 2019 in China has spread over all countries of
the world within few month acquiring a pandemic nature, the incident population counting …
the world within few month acquiring a pandemic nature, the incident population counting …
Pharmacological treatments of COVID-19
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …
which was reported for the first time in December 2019, was named by the World Health …
[PDF][PDF] Various evidence-based hypothetical and experimental treatment approaches and their effectiveness against COVID-19 worldwide: a comprehensive literature …
Several drugs are presently undergoing clinical studies to investigate their efficacy and
safety in the handling of 2019 coronavirus disease (COVID-19). Despite of the fact, certain …
safety in the handling of 2019 coronavirus disease (COVID-19). Despite of the fact, certain …
[HTML][HTML] Current status of COVID-19 treatment: An opinion review
The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
has garnered the attention of scientists worldwide in the search for an effective treatment …
has garnered the attention of scientists worldwide in the search for an effective treatment …
Evolving pharmaceutical therapies for confronting COVID-19: An overview
R Ghai, K Nagarajan, T Mishra, S Vats… - AIP Conference …, 2022 - pubs.aip.org
December 2019 was marked by the arrival of the novel coronavirus, which has now
reportedly resulted in 4,200,412 deaths (as ofJuly 30, 2021) world-wide. Although the …
reportedly resulted in 4,200,412 deaths (as ofJuly 30, 2021) world-wide. Although the …
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
YW Zhou, Y Xie, LS Tang, D Pu, YJ Zhu… - Signal transduction and …, 2021 - nature.com
Owing to the limitations of the present efforts on drug discovery against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of the understanding of the …
Potential drug options for treatment of COVID-19: A review
A virus known as novel corona (SARS-CoV-2) which causes COVID-19 pandemic disease is
an invisible enemy, appeared for the first time in the world's most populous country, China …
an invisible enemy, appeared for the first time in the world's most populous country, China …
[PDF][PDF] Distinctive Therapeutic Strategies against Corona Virus19 (COVID-19): A Pharmacological Review.
YA Nomier, DS Rao, AH Suhaqi… - Systematic Reviews in …, 2020 - researchgate.net
Coronaviruses (CoVs) are RNA viruses threatened the global health. The causative
microorganism, causing coronavirus disease-2019 (COVID-19), is known as (novel …
microorganism, causing coronavirus disease-2019 (COVID-19), is known as (novel …
[PDF][PDF] Pharmacological treatments of covid-19-a review
JM Cherumanalil, J Thayyil - Asian J Pharm Clin Res, 2020 - kmctmedicalcollege.org
Now the world stands in the fight against coronavirus disease 2019 (COVID-19), with its
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …
Current scenario and future prospect in the management of COVID-19
P Borah, PK Deb, S Deka… - Current Medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …
assessment, rapid spreading ability, and propensity to precipitate severe disease in …